CS921385A2 - Zpusob vyroby nove 6 fluor 7 (pyrrol l yl) 1 cyklopropyl l,4 dihydro 4 oxochinolin 3 karboxylove kyseliny - Google Patents

Zpusob vyroby nove 6 fluor 7 (pyrrol l yl) 1 cyklopropyl l,4 dihydro 4 oxochinolin 3 karboxylove kyseliny

Info

Publication number
CS921385A2
CS921385A2 CS859213A CS921385A CS921385A2 CS 921385 A2 CS921385 A2 CS 921385A2 CS 859213 A CS859213 A CS 859213A CS 921385 A CS921385 A CS 921385A CS 921385 A2 CS921385 A2 CS 921385A2
Authority
CS
Czechoslovakia
Prior art keywords
radical
pyrrol
dihydro
karboxylove
cyklopropyl
Prior art date
Application number
CS859213A
Other languages
English (en)
Other versions
CS258136B2 (en
Inventor
Esteve J Soler
Original Assignee
Provesan Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Provesan Sa filed Critical Provesan Sa
Publication of CS921385A2 publication Critical patent/CS921385A2/cs
Publication of CS258136B2 publication Critical patent/CS258136B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS859213A 1984-12-12 1985-12-12 Method of new 6-fluoro-7(pyrrol-1-yl)-1-cyclopropyl-1,4--dihydro-4-oxoquinoline-3-carboxyl acid production CS258136B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8419001A FR2574404B1 (fr) 1984-12-12 1984-12-12 Derives 1-substitues de l'acide 6-fluoro-7-(pyrrol-1-yl)-1,4-dihydro-4-oxoquinoleine-3-carboxylique, leur preparation et leur application en tant que medicaments

Publications (2)

Publication Number Publication Date
CS921385A2 true CS921385A2 (en) 1987-12-17
CS258136B2 CS258136B2 (en) 1988-07-15

Family

ID=9310528

Family Applications (1)

Application Number Title Priority Date Filing Date
CS859213A CS258136B2 (en) 1984-12-12 1985-12-12 Method of new 6-fluoro-7(pyrrol-1-yl)-1-cyclopropyl-1,4--dihydro-4-oxoquinoline-3-carboxyl acid production

Country Status (15)

Country Link
US (1) US4727080A (cs)
EP (1) EP0187085B1 (cs)
JP (1) JPS61197577A (cs)
AT (1) ATE56446T1 (cs)
CS (1) CS258136B2 (cs)
DD (1) DD242042A5 (cs)
DE (1) DE3579683D1 (cs)
ES (1) ES8704930A1 (cs)
FR (1) FR2574404B1 (cs)
HU (1) HU195802B (cs)
PL (1) PL146541B1 (cs)
PT (1) PT81652B (cs)
RO (1) RO93482B (cs)
SU (1) SU1426453A3 (cs)
YU (1) YU43691B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3519286A1 (de) * 1985-05-30 1986-12-04 Bayer Ag, 5090 Leverkusen 7-azolyl-1-cyclopropyl-1,4-dihydro-4-oxo-3- chinolincarbonsaeuren und -1,8-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US5153204A (en) * 1986-03-01 1992-10-06 Bayer Aktiengesellschaft 7-(1-Pyrrolidinyl)-quinolonecarboxylic acid derivatives
DE3606698A1 (de) * 1986-03-01 1987-09-03 Bayer Ag 7-(1-pyrrolidinyl)-chinoloncarbonsaeure -derivate
DE3639465A1 (de) * 1986-11-18 1988-05-19 Hoechst Ag Optisch aktive gyrasehemmer, ihre herstellung und verwendung als antibiotika
FR2629456B1 (fr) * 1988-03-31 1991-07-05 Esteve Labor Dr Derives des acides 7-(1-imidazolyl),1,4-dihydro-4-oxo-6,8-difluoro-1-cyclopropyl-3-quinoleincarboxylique, leur preparation et leur application en tant que medicaments
US5039682A (en) * 1988-06-21 1991-08-13 Pfizer Inc. 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor
US5104868A (en) * 1988-06-21 1992-04-14 Pfizer Inc. Tricyclic derivatives of 7-substituted-6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acids and esters
US5103040A (en) * 1988-06-21 1992-04-07 Pfizer Inc. 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor
US5233091A (en) * 1988-06-21 1993-08-03 Pfizer Inc. 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor
WO1991001308A1 (fr) * 1989-07-21 1991-02-07 Ss Pharmaceutical Co., Ltd. Derives de l'acide quinolonecarboxylique
US20070275994A1 (en) * 2003-06-06 2007-11-29 Lohray Braj B Novel Antinfective Compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292317A (en) * 1977-09-20 1981-09-29 Laboratorie Roger Bellon 1,4-Dihydro-quinoline-3-carboxylic acid derivatives, process for their preparation and compositions containing them
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
SE440354B (sv) * 1981-02-19 1985-07-29 Kyorin Seiyaku Kk Kinolinkarboxylsyraderivat
US4499091A (en) * 1982-03-31 1985-02-12 Sterling Drug Inc. 1-Amino (or substituted amino)-1,4-dihydro-4-oxo-6-fluoro-7-heterylquinoline-3-carboxylic acids and their use as antibacterial agents
DE3248507A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen Mikrobizide mittel auf chinoloncarbonsaeure basis
FR2559484B2 (fr) * 1983-07-06 1986-09-26 Provesan Sa Nouveau derive 7-(pyrrol-1-yl) de l'acide 1-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridin)-3-carboxylique, sa preparation et son application en tant que medicament
IT1221492B (it) * 1984-03-13 1990-07-06 Biochem Design Srl Acidi 7-(1-pirril)-e 7-(1-pirroli-dinil)-6-fluoro-1-etil-1,4-diidro-4-chetochinolin-3-carbossilici ad attivita' antimicrobiche,loro procedimento di preparazione e composti farmaceutici che li contengono
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
US4636506A (en) * 1984-12-06 1987-01-13 Pfizer, Inc. 7-heterocyclic-1,4-dihydroquinolones

Also Published As

Publication number Publication date
EP0187085A1 (fr) 1986-07-09
YU43691B (en) 1989-10-31
PT81652A (fr) 1986-01-01
FR2574404A1 (fr) 1986-06-13
YU192385A (en) 1988-04-30
FR2574404B1 (fr) 1987-04-24
EP0187085B1 (fr) 1990-09-12
DE3579683D1 (de) 1990-10-18
ATE56446T1 (de) 1990-09-15
PL146541B1 (en) 1989-02-28
RO93482A (ro) 1987-12-31
HUT40640A (en) 1987-01-28
CS258136B2 (en) 1988-07-15
ES550689A0 (es) 1987-05-01
DD242042A5 (de) 1987-01-14
SU1426453A3 (ru) 1988-09-23
ES8704930A1 (es) 1987-05-01
JPS61197577A (ja) 1986-09-01
PL256757A1 (en) 1986-10-07
PT81652B (pt) 1988-04-21
HU195802B (en) 1988-07-28
RO93482B (ro) 1988-01-02
JPH0312064B2 (cs) 1991-02-19
US4727080A (en) 1988-02-23

Similar Documents

Publication Publication Date Title
GB8823567D0 (en) 4h-1-benzopyran-4-one derivative/its salt & process for producing same
LU91076I9 (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
IL88901A0 (en) Substituted pyrrole,pyrazole and triazole derivatives,their preparation and pharmaceutical compositions containing them
CA2263913A1 (en) Substituted 6,6-hetero-bicyclic derivatives
HUT55369A (en) Herbicidal compositions and process for producing sulfonylamino-carbonyl triazolinone derivatives and their intermediates used as active ingredient
ES2010114A6 (es) Procedimiento de preparacion de derivados de los acidos 1,4-dihidro-4-oxoquinolein-3-carboxilicos.
NZ240378A (en) Substituted thiazolidinedione derivatives; pharmaceutical compositions,
CS921385A2 (en) Zpusob vyroby nove 6 fluor 7 (pyrrol l yl) 1 cyklopropyl l,4 dihydro 4 oxochinolin 3 karboxylove kyseliny
EP0422485A3 (en) Quinolone carboxylic acid derivatives, process for their preparation and their use
CA2337098A1 (en) Anthranilic acid derivatives
WO1992014696A3 (en) SUBSTITUTED α-AMINOALDEHYDES AND DERIVATIVES
ZA94841B (en) Novel derivatives of quinolonecarboxylic acid and naphthyridonecarboxylic acid
GR3017384T3 (en) Process for the preparation of 2,7-Diazabicyclo(3.3.O)octanes.
KR960004860B1 (en) Substituted pyridine-2,4-dicarboxylic acid compounds and the use thereof and medicaments
PT85358B (en) Process for the preparation of improved fungicidal compositions containig a synergic mixture of alpha-(4-chlorophenyl)-alpha- (1-cyclopropylethyl)-1h-1,2,4-thiazole-1-ethanol with 1,1'-im ine-dicoctamethylene-diguanidine and/or their salts
CA2095338A1 (en) Individual stereoisomers of 7-¬3-(aminoalkyl)-1-pyrrolidinyl|-quinolonesand naphthyridones as antibacterial agents
ZA981430B (en) Anticancer composition
CA2290557A1 (en) Use of 4-substituted tetrahydropyridines for making medicines acting on tgf-.beta.1
IL71068A0 (en) N-arylpiperazine derivative,its preparation and pharmaceutical compositions containing it
EP0476156A4 (en) Solid oral preparation containing catechol compound
AU1099688A (en) Substituted 3-phenyl-7h-thiazolo(2,2-b)(1,2,4)triazin-7-ones, a process for the preparation thereof, medicaments containing same and the use thereof, and also some intermediates formed in the preparation of the compounds mentioned
AU8490991A (en) Substituted 2 imidazolone derivatives, their preparation and pharmaceutical compositions
EP0509098A4 (en) Ataractic
IL85508A (en) 2-substituted-4-(2-benzyl-aminophenyl)-1,4,5,7-tetra-hydro-5-oxofuro(3,4,-b)-pyridine-3-carboxylic acid derivatives and pharmaceutical compositions containing them
IT1247921B (it) Composti ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono